# Dogwood Therapeutics, Inc.: Form 8-K, filed Nov 7, 2024

- Company: [Dogwood Therapeutics, Inc.](/companies/dwtx.md) (CIK 1818844)
- Form: 8-K
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 07:15 ET
- Period: 2024-11-07
- Accession: 0001558370-24-014749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024014749/viri-20241107x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818844/000155837024014749/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818844/000155837024014749/viri-20241107x8k.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-014749. Last ingested by Listed: Oct 30, 2026, 16:07 ET. No prices; not investment advice.